Table 3.
Pulmonary function tests (PFT) interpretation by severity.
Frija-Masson et al, 2020& | Huang et al, 2020 | Mo et al, 2020 | You et al, 2020 | |||||
---|---|---|---|---|---|---|---|---|
PFT Interpretation | Non-severe | Severe | Non-severe | Severe | Non-severe | Severe | Non-severe | Severe |
n = 29 | n = 16 | n = 40 | n = 17 | n = 91 | n = 19 | n = 12 | n = 6 | |
Restrictive, n (%) | 5 (17.2) | 8 (50) | 2 (5)# | 4 (23.5)# | 8 (8.8)# | 2 (10.53)# | 1 (8.3) | 2 (33.3) |
3 (7.5)## | 4 (23.5)## | 18 (19.8)## | 9 (47.37)## | |||||
Obstructive, n (%) | NR | NR | NR | NR | 5 (5.5)* | 0 (0)* | 3 (16.7) | 0 (0) |
Altered difusión, n (%) | 7 (24.2) | 5 (31.25) | 17 (42.5)** | 13 (76.5)** | 35 (38.5)** | 16 (84.21)** | NR | NR |
Time of assessment | 30 days after symptoms onset | 30 days after discharge from the hospital | 27.9 ± 7 days after the onset of disease | 38 ± 13.4 days after hospital discharge |
#Author reported values lower 80% predicted FVC.
##Author reported values lower 80% predicted TLC.
*Author reported values lower 70% predicted FEV1/FVC.
**Author reported values lower 80% predicted DLCO.
&Only 45 patients were classified by severity.